Christopher Jorgensen
Direttore/Membro del Consiglio presso Vapogenix, Inc.
Profilo
Christopher Jorgensen is currently the Director at Vapogenix, Inc. and the Managing Director at Pamoja Capital SA. He has an undergraduate degree from the Woodrow Wilson School of Public & International Affairs.
Posizioni attive di Christopher Jorgensen
Società | Posizione | Inizio |
---|---|---|
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
Pamoja Capital SA
Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - |
Formazione di Christopher Jorgensen
Woodrow Wilson School of Public & International Affairs | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Health Services |
Pamoja Capital SA
Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Finance |
- Borsa valori
- Insiders
- Christopher Jorgensen